Gf Fund Management Co. Ltd. Cytokinetics Inc Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Cytokinetics Inc stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,021 shares of CYTK stock, worth $97,971. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,021
Previous 2,478
21.91%
Holding current value
$97,971
Previous $117 Million
4.16%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$476 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$384 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$323 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$259 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$197 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.05B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...